These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
795 related articles for article (PubMed ID: 26388691)
41. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery. Shang Q; Huang S; Zhang A; Feng J; Yang S J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380 [TBL] [Abstract][Full Text] [Related]
42. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
43. Combination of a Bioceramic Scaffold and Simvastatin Nanoparticles as a Synthetic Alternative to Autologous Bone Grafting. Wang CZ; Wang YH; Lin CW; Lee TC; Fu YC; Ho ML; Wang CK Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567319 [TBL] [Abstract][Full Text] [Related]
44. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells. Kavas A; Keskin D; Altunbaş K; Tezcaner A Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363 [TBL] [Abstract][Full Text] [Related]
45. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide. O'Donnell A; Moollan A; Baneham S; Ozgul M; Pabari RM; Cox D; Kirby BP; Ramtoola Z J Pharm Pharmacol; 2015 Apr; 67(4):525-36. PubMed ID: 25515568 [TBL] [Abstract][Full Text] [Related]
46. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614 [TBL] [Abstract][Full Text] [Related]
47. Spermidine-mediated poly(lactic- Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114 [TBL] [Abstract][Full Text] [Related]
48. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
49. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459 [TBL] [Abstract][Full Text] [Related]
51. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018 [TBL] [Abstract][Full Text] [Related]
52. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094 [TBL] [Abstract][Full Text] [Related]
53. Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy. Molavi O; Mahmud A; Hamdy S; Hung RW; Lai R; Samuel J; Lavasanifar A Mol Pharm; 2010 Apr; 7(2):364-74. PubMed ID: 20030320 [TBL] [Abstract][Full Text] [Related]
56. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori. Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052 [TBL] [Abstract][Full Text] [Related]
57. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo. Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390 [TBL] [Abstract][Full Text] [Related]
58. Intracellular drug delivery in Leishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles. Van de Ven H; Vermeersch M; Vandenbroucke RE; Matheeussen A; Apers S; Weyenberg W; De Smedt SC; Cos P; Maes L; Ludwig A J Drug Target; 2012 Feb; 20(2):142-54. PubMed ID: 22080813 [TBL] [Abstract][Full Text] [Related]
59. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. Girotra P; Singh SK; Kumar G Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690 [TBL] [Abstract][Full Text] [Related]
60. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]